Ethyl 2-amino-5-bromothiophene-3-carboxylate, 95.0%, 250mg

2-Piperidinecarboxylic acid, 1-[(2S)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-, hydrate (1:1), (2R,4R)-, 99%, 25mg

3',4',5',6'-Tetrahydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one, 85.0%, 10g

3-(3-Bromophenyl)-2-hydroxypropanoic acid, 95%, 250mg

Ethyl 2-(3,5-dichloropyridin-4-yl)acetate, 98%, 1g

methyl 2-oxo-1,3-oxazolidine-5-carboxylate, 95.0%, 250mg

4-Bromo-N-isopropylbenzenesulfonamide, 95.0%, 5g

tert-Butyl (3aS,7aS)-octahydro-6H-pyrrolo[2,3-c]pyridine-6-carboxylate, 98%, 500mg

methyl 4-bromo-1H-1,2,3-benzotriazole-6-carboxylate, 98%, 5g

(5-Chlorothiophen-2-yl)methanol, 95.0%, 10g

2-Cyclobutyl-1,3-thiazole-5-carbaldehyde, 98%, 5g

1-hexyl-1,4-diazepane, 95.0%, 2g

Ácido nitrilotriacético, mínimo 99 %, pa, ACS, 100 g, envase de plástico.